Introduction

Strategies & Considerations for Trace Detection of Fentalogs

Strategies & Considerations for Trace Detection of Fentalogs

← Back to Series 

Overview

This webinar provides strategies & considerations for the trace detection of fentanyl and its analogs. The focus will be on TD-DART-MS and IMS analysis as well as understanding the fate of fentanyl residues that are exposed to different environments.

Fentanyl and fentanyl analogs pose a significant and ever changing threat in the United States as both pure compounds and in complex mixtures. While commonly considered detection techniques require visible amounts of powder (i.e. color tests or GC/MS analysis), trace detection and identification methods present both a unique opportunity and a unique set of challenges. Rapid detection of non-visible residues containing fentanyl, or similar compounds, can be extremely useful in minimizing exposure of law enforcement at scenes, assessing public health implications, triaging evidence in forensic laboratories, and intelligence gathering. For trace detection to be successful the technique needs to be rapid, specific, capable of handling complex background matrices, and minimize the risk of exposure to the analyst. There also must be confidence that a detectable level of residue exists on the surface and remains present on the surface after exposure to the environment. This webinar will highlight two potential tools for the trace detection of fentanyl and NPS residues, thermal desorption direct analysis in real time mass spectrometry (TD-DART-MS) and ion mobility spectrometry (IMS) while also providing context to the issues of expected residue contamination levels and environmental stability.

A certificate of completion is available for all who register and attend this webinar.

Presenter

  • Ed Sisco

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

Success Story: NIJ and The Virginia Department of Forensic Science Advancing Drug Analysis in Forensic Toxicology for Enhanced Judicial Outcomes

National Institute of Justice and the Virginia Department of Forensic Science Date July 2024 Overview The Virginia Department of Forensic Science (DFS) developed two novel analytical methods using liquid chromatography tandem mass spectrometry (LC-MS/MS) to improve efficiency, detection, and productivity…

Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

White Paper – Forensic Community Drug Database Conceptualization

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…